142 related articles for article (PubMed ID: 15609351)
1. Binding of recombinant PrPc to human plasminogen: kinetic and thermodynamic study using a resonant mirror biosensor.
Cuccioloni M; Amici M; Eleuteri AM; Biagetti M; Barocci S; Angeletti M
Proteins; 2005 Feb; 58(3):728-34. PubMed ID: 15609351
[TBL] [Abstract][Full Text] [Related]
2. Binding of disease-associated prion protein to plasminogen.
Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
4. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
5. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
6. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
7. Identification of proteins with high affinity for refolded and native PrPC.
Petrakis S; Sklaviadis T
Proteomics; 2006 Dec; 6(24):6476-84. PubMed ID: 17111435
[TBL] [Abstract][Full Text] [Related]
8. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein.
Sandmeier E; Hunziker P; Kunz B; Sack R; Christen P
Biochem Biophys Res Commun; 1999 Aug; 261(3):578-83. PubMed ID: 10441469
[TBL] [Abstract][Full Text] [Related]
10. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
Breydo L; Bocharova OV; Baskakov IV
Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
[TBL] [Abstract][Full Text] [Related]
11. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
13. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
14. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
Triantaphyllidou IE; Sklaviadis T; Vynios DH
Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
[TBL] [Abstract][Full Text] [Related]
15. The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
Granata V; Palladino P; Tizzano B; Negro A; Berisio R; Zagari A
Biopolymers; 2006 Jun; 82(3):234-40. PubMed ID: 16489585
[TBL] [Abstract][Full Text] [Related]
16. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
Hesp JR; Raven ND; Sutton JM
Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
[TBL] [Abstract][Full Text] [Related]
17. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
[TBL] [Abstract][Full Text] [Related]
18. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
19. Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse.
Kuczius T; Grassi J; Karch H; Groschup MH
FEBS J; 2007 Mar; 274(6):1492-502. PubMed ID: 17302739
[TBL] [Abstract][Full Text] [Related]
20. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
